A5077093612- Prostate Cancer Diagnosis and Treatment
- Urinary Bladder and Prostate Research
- Prostate Cancer Treatment and Research
- Pelvic floor disorders treatments
- Urological Disorders and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Hormonal and reproductive studies
- Acute Ischemic Stroke Management
- Urologic and reproductive health conditions
- Intracranial Aneurysms: Treatment and Complications
- Social Media in Health Education
- Bladder and Urothelial Cancer Treatments
- Cancer, Lipids, and Metabolism
- Sexual function and dysfunction studies
- Patient-Provider Communication in Healthcare
- Urinary Tract Infections Management
- Advanced Radiotherapy Techniques
- Cardiac, Anesthesia and Surgical Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Genital Health and Disease
- Spacecraft Design and Technology
- Health Literacy and Information Accessibility
- Intraocular Surgery and Lenses
- Ureteral procedures and complications
- Kidney Stones and Urolithiasis Treatments
The University of Sydney
2015-2025
Sydney Adventist Hospital
2016-2025
Australian National University
2021-2025
Chris O’Brien Lifehouse
2017-2025
Blacktown & Mount Druitt Hospital
2023-2025
Western Sydney University
2024-2025
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2019-2024
Cancer Trials Australia
2023-2024
Hofstra University
2021-2024
TESLA (Czechia)
2024
Background and Purpose— The current report details our initial periprocedural experience with Wingspan (Boston Scientific/Target), the first self-expanding stent system designed for treatment of intracranial atheromatous disease. Methods— All patients undergoing angioplasty stenting Gateway balloon–Wingspan were prospectively tracked. Results— During a 9-month period, was attempted in 78 (average age, 63.6 years; 33 women) 82 lesions, which 54 ≥70% stenotic. Eighty-one lesions successfully...
Patients with prostate cancer who have high-risk biochemical recurrence an increased risk of progression. The efficacy and safety enzalutamide plus androgen-deprivation therapy monotherapy, as compared alone, are unknown. Download a PDF the Research Summary. In this phase 3 trial, we enrolled patients had prostate-specific antigen doubling time 9 months or less. were randomly assigned, in 1:1:1 ratio, to receive (160 mg) daily leuprolide every 12 weeks (combination group), placebo...
Importance Recent large infarct thrombectomy trials used heterogeneous imaging modalities and time windows for patient selection. Noncontrast computed tomographic (CT) scan is the most common stroke approach. It remains uncertain whether effective patients with infarcts identified using noncontrast CT alone within 24 hours of onset. Objective To evaluate effect in a on Design, Setting, Participants Open-label, blinded–end point, bayesian-adaptive randomized trial interim analyses early...
Intracranial atherosclerotic disease and resultant intracranial stenosis is a global leading cause of stroke, poses an ongoing treatment challenge. Among patients with stenosis, those hemodynamic compromise are at high risk for recurrent stroke despite medical therapy factor modification. Revascularization the hypoperfused territory most plausible strategy these high-risk patients, yet surgical endovascular therapies have not shown to be sufficiently safe effective in randomized controlled...
OBJECTIVE Wingspan (Boston Scientific, Fremont, CA) is a self-expanding stent designed specifically for the treatment of symptomatic intracranial atheromatous disease. The current series reports observed incidence in-stent restenosis (ISR) and thrombosis on angiographic follow-up. METHODS A prospective, intent-to-treat registry patients in whom system was used to treat disease maintained at five participating institutions. Clinical follow-up results were recorded. ISR defined as stenosis...
<b>BACKGROUND AND PURPOSE:</b> Wingspan is a self-expanding, microcatheter-delivered microstent specifically designed for the treatment of symptomatic intracranial atherosclerotic disease. Our aim was to discuss effect patient age and lesion location on in-stent restenosis (ISR) rates after percutaneous transluminal angioplasty stenting (PTAS) with system. <b>MATERIALS METHODS:</b> Clinical angiographic follow-up results were recorded all patients from 5 participating institutions. ISR...
Delayed in-stent stenosis is an important and well-characterized complication of angioplasty stenting for the treatment intra- extracranial atheromatous disease. The current series describes incidence natural history after deployment Neuroform stent within cerebrovasculature aneurysms.The collaborative Cleveland Clinic Foundation-Barrow Neurological Institute endovascular database was reviewed to identify cases delayed moderate or severe observed during follow-up cerebral aneurysms treated...
To characterise the use of social media among members American Urological Association (AUA), as in medicine has greatly expanded recent years.In December 2012 to January 2013, AUA e-mailed a survey with 34 questions on 2000 randomly selected urologists and 2047 resident/fellow members. Additional data was collected from Symplur analytics surrounding Annual Meeting May 2013.In all, 382 (9.4%) surveys were completed, indicating 74% responders had an online account. The most commonly used...
Study Type – Therapy (case series) Level of Evidence 4 What’s known on the subject? and What does study add? Most surgical treatments for benign prostatic hyperplasia procedural involve removal or destruction prostate tissue these approaches are commonly associated with treatment related morbidity. Unlike other therapies, urethral lift mechanically opens urethra using tensioned sutures that compress between capsule. This is first publication this technology. manuscript reports confirms its...